Little House Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$843K Buy
13,440
+67
+0.5% +$5.36K 0.22% 89
2025
Q4
$1.28M Buy
13,373
+3,443
+35% +$338K 0.32% 68
2025
Q3
$969K Buy
9,930
+141
+1% +$14.6K 0.22% 92
2025
Q2
$1.05M Buy
9,789
+424
+5% +$42.9K 0.26% 85
2025
Q1
$945K Buy
+9,365
New +$943K 0.26% 87
2022
Q1
Sell
-6,865
Closed -$292K 134
2021
Q4
$292K Buy
6,865
+43
+0.6% +$1.81K 0.15% 122
2021
Q3
$296K Buy
6,822
+612
+10% +$27.1K 0.17% 114
2021
Q2
$266K Buy
+6,210
New +$261K 0.14% 125

Other funds holding BSX

Little House Capital's BSX Position: Q1 2026 in Review

Little House Capital increased its Boston Scientific (BSX) stake by 0.5% in Q1 2026, buying an estimated $5.36K and bringing the position to 13,440 shares worth $843K. The position accounts for 0.22% of the portfolio, ranked #89.

Little House Capital first reported a position in BSX in Q2 2021 and has held it in 8 quarters since. The position peaked at $1.28M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Little House Capital held 13,440 shares of Boston Scientific worth $843K as of Q1 2026.
  • Little House Capital bought 67 Boston Scientific shares in Q1 2026, an estimated $5.36K.
  • Boston Scientific made up 0.22% of Little House Capital's portfolio in Q1 2026, its #89 holding.
  • Little House Capital first reported a position in Boston Scientific in Q2 2021 and has held it in 8 quarters since.
  • Little House Capital's Boston Scientific position peaked at $1.28M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Little House Capital's 13F filing for Q1 2026, filed 7 May 2026.